Evidence map›Paper›PMID 25359006›Full record

ArticleScientific reports2014

Calmodulin-like protein from M. tuberculosis H37Rv is required during infection.

Meeta J Advani, Malini Rajagopalan, P Hemalatha Reddy

Abstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Protein Architecture and Composition in Mycobacterium tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. Article
  4. Calcium Regulation of Bacterial Virulence.Advances in experimental medicine and biology · 2020
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Meeta J AdvaniDepartment of Biochemistry, Sri Venkateswara College, University of Delhi South Campus, New Delhi - 110 021, INDIA.
Malini RajagopalanBiomedical Research, The University of Texas Health Center at Tyler, Tyler, Texas- 75708-3154, United States.
P Hemalatha ReddyDepartment of Biochemistry, Sri Venkateswara College, University of Delhi South Campus, New Delhi - 110 021, INDIA.

Funding

Mycobacterium tuberculosis cell division and proliferationR01AI048417 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI RAJAGOPALAN, MALINI · 2000 to 2011
$3.0M
NIAID NIH HHS AI48417NIAID NIH HHS R01 AI048417
6 · The paper itself

Abstract

M. tuberculosis constitutes very sophisticated signaling systems that convert the environment signals into appropriate cellular response and helps the bacilli to overcome the onslaught of host defence mechanisms. Although mycobacterial two-component systems and STPKs have gained lot of attention as virulence factors, mycobacterial calcium signaling has not been very well studied. Calcium signaling has been the primary mechanism in eukaryotes for regulation of kinases, however in prokaryotes auto-phosphorylation of number of kinases has been reported. We have previously reported a small calmodulin-like-protein (CAMLP) from M. tuberculosis regulating enzymes of heterogeneous origin. To understand its role in both viability and virulence, we have assessed the effect of reduced expression of CAMLP coding gene Rv1211 on M. tb growth in vitro and ex vivo. Further, we have also studied the expression profile of Rv1211 in various conditions simulating host microenvironments. Our results highlight the possible role of CAMLP in growth and survival of M. tb during infection.

Indexed as

Bacterial ProteinsCalmodulinGene ExpressionGene Expression Regulation, BacterialMacrophagesMycobacterium tuberculosisPlasmidsTuberculosisBacterial ProteinsCalmodulin

Identifiers

PMID25359006
PMCPMC4215301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.